BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16508636)

  • 1. Late recurrences of germ cell malignancies: a population-based experience over three decades.
    Oldenburg J; Alfsen GC; Waehre H; Fosså SD
    Br J Cancer; 2006 Mar; 94(6):820-7. PubMed ID: 16508636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late relapse of germ cell tumors.
    Oldenburg J; Wahlqvist R; Fosså SD
    World J Urol; 2009 Aug; 27(4):493-500. PubMed ID: 19373473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
    Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
    Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retroperitoneal residual tumor resection after chemotherapy of malignant testicular cancers].
    Albers P
    Aktuelle Urol; 2012 May; 43(3):197-206. PubMed ID: 22639031
    [No Abstract]   [Full Text] [Related]  

  • 5. Late Relapse of Nonseminomatous Germ Cell Tumor 24 Years Later.
    Riedinger CB; Labbate C; Werntz RP; Eggener SE
    Urology; 2018 Dec; 122():16-18. PubMed ID: 30170087
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors.
    Nguyen CT; Stephenson AJ
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):593-604, ix. PubMed ID: 21570611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
    Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
    J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The surgery after. . . retroperitoneal lymph node dissection and surgery of the residual masses after chemotherapy for advanced testicular cancer].
    Guillemin F; Belinga JF; Marchal F; Rauch P; Verhaeghe JL
    Bull Cancer; 2011 Jan; 98(1):43-51. PubMed ID: 21300599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
    Considine S; Heaney R; Conroy R; Thornhill JA
    Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-centre observational study of surgery and late malignant events after chemotherapy for germ cell cancer.
    Ravi R; Oliver RT; Ong J; Badenoch DF; Fowler CG; Paris AM; Hendry WF
    Br J Urol; 1997 Oct; 80(4):647-52. PubMed ID: 9352707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.
    Mano R; Becerra MF; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Feldman DR; Sheinfeld J
    J Urol; 2017 Feb; 197(2):391-397. PubMed ID: 27720783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
    Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY
    Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of clinical stage I testicular germ cell tumours].
    Loriot Y; Fizazi K
    Bull Cancer; 2007 May; 94(5):439-48. PubMed ID: 17535781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late relapse of germ cell tumors.
    Oldenburg J; Lorch A; Fosså SD
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):615-26, x. PubMed ID: 21570613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metachronous bilateral testicular germ cell tumors: report of two cases.
    James FV; Kumar A; Jayaprakash PG; Mathews A
    J Cancer Res Ther; 2009; 5(3):206-7. PubMed ID: 19841564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?
    Riggs SB; Burgess EF; Gaston KE; Merwarth CA; Raghavan D
    Oncologist; 2014 May; 19(5):498-506. PubMed ID: 24718515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.